Genentech Bid To Gain Full Approval For Avastin On Amassed PFS Data Gets July ODAC Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche division also seeks approval for bevacizumab in new combinations based on AVADO and RIBBON-1 trial results, but the question remains whether the progression-free survival endpoint used in all the trials is sufficient for full approval.